Narvitas Medical Devices International Limited Announces the first successful Bariatric application of its Proprietary LapDome Device

LONDON - May 30, 2016 - PRLog -- Narvitas Medical Devices International Limited, a UK-based global medical device company, today announced the successful use of its LapDome in a patient that would be medically categorized as morbidly obese. LapDome, the first commercially available laparoscopic surgery access device, is designed to provide safer and more rapid access to the abdominal cavity at the outset of laparoscopic surgery.

The procedure was performed on a patient weighing 308 lbs. with a body mass index of 49 by Andreas Thurkow, MD, in the Netherlands. Following the successful surgery, Dr. Thurkow commented, "If I did not have LapDome at my disposal today, I would not have been able to perform that operation laparoscopically."

"Based on clinical experience to date we know LapDome to be an effective surgical tool in enhancing laparoscopic surgery access and increasing safety for the patient through its unique design," said Glenn Foley, Chairman and Chief Executive Officer of Narvitas. "We now have the beginnings of examining the utility of LapDome to treat a patient population outside the norm and potentially expand the utility of laparoscopic surgery to patients who may have been deemed inappropriate for laparoscopic surgery and relegated to standard surgery with all its relative shortcomings."

About LapDome^® Laparoscopic Access Device

LapDome addresses a critical need in the laparoscopic surgical market (one of the largest medical procedure markets) and was developed to advance the standard of care for laparoscopic access. The LapDome device is a proprietary laparoscopic surgery access device. The device is a dome-shaped technology that utilizes negative pressure to raise the anterior abdominal wall for rapid and safe access to the abdominal cavity by surgical instruments.

http://www.narvitas.com